Nateglinide
increases insulin absolution by inhibiting ATP-sensitive potassium channels in
a glucose-dependent manner.
Nateglinide
action is abased on the attendance activity β beef and glucose. In adverse to
sulfonylurea insulin secretatogogues, nateglinide has no aftereffect on insulin
absolution in the absence of glucose. Rather, it potentiates the aftereffect of
extracellular glucose on ATP-sensitive potassium approach and has little
aftereffect on insulin levels amid commons and overnight. As such, nateglinide
is added able at abbreviation postprandial claret glucose levels than
abnegation claret glucose levels and requires a best continuance of analysis
(approximately one month) afore decreases in abnegation claret glucose are
observed. The insulinotropic furnishings of nateglinide are accomplished at
average glucose levels (3 to 10 mmol/L) and it does not access insulin
absolution already angry by top glucose concentrations (greater than 15
mmol/L). Nateglinide appears to be careful for pancreatic β beef and does not
arise to affect ashen or cardiac beef or thyroid tissue.